Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 3Plasma cell 1Lymphoid 1

Conditions

Lymphoma 159Precursor Cell Lymphoblastic Leukemia-Lymphoma 130Leukemia 72Lymphoma, Large B-Cell, Diffuse 61Leukemia, Lymphocytic, Chronic, B-Cell 56Burkitt Lymphoma 56Hodgkin Disease 55Lymphoma, Follicular 47Lymphoma, Non-Hodgkin 43Lymphoma, Mantle-Cell 35Lymphoma, Large-Cell, Anaplastic 32Leukemia, Myeloid, Acute 27Lymphoma, B-Cell, Marginal Zone 25Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 24Lymphoma, Large-Cell, Immunoblastic 24Leukemia, Biphenotypic, Acute 24Waldenstrom Macroglobulinemia 23Recurrence 21Lymphoma, T-Cell, Cutaneous 21Mycosis Fungoides 18Dendritic Cell Sarcoma, Interdigitating 18Sezary Syndrome 16Immunoblastic Lymphadenopathy 14Myelodysplastic Syndromes 13Leukemia, Myelomonocytic, Juvenile 13Leukemia, Myelomonocytic, Chronic 13Central Nervous System Neoplasms 13Myeloproliferative Disorders 12Multiple Myeloma 12Blast Crisis 12

Interventions

Crizotinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Sarcoma, Clear Cell × Lymphoid × Clear all
NCT01524926 2023-12-11

CREATE

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Completed
582 enrolled
LymphoidPlasma cellSarcoma

Granuloma, Plasma Cell, Lymphoma, Large-Cell, Anaplastic, Sarcoma, Clear Cell, Rhabdomyosarcoma, Alveolar, Sarcoma, Alveolar Soft Part

Data powered by HemOnc (CC BY 4.0) Colophon âš¡